ScreenerHero

FAE Faes Farma, S.A.

BME · ES · Healthcare · Drug Manufacturers - Specialty & Generic · faesfarma.com
4.600EUR+1.55%Mkt Cap: 1.56B $P/E: 17.04

Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally. The company operates through Pharmaceutical and Healthcare Specialties; Anima…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$64.30BUSDP/E 25.0
TAK
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
$57.06BUSD
TEVA
Teva Pharmaceutical Industries Limited Ordinary Shares
$46.10BUSDP/E 65.9
HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$38.70BUSDP/E 18.3
ZOE
Zoetis Inc.
$28.27BUSDP/E 12.1
ZTS
Zoetis Inc. Class A Common Stock
$28.80BUSDP/E 11.4
UTHR
United Therapeutics Corporation - Common Stock
$23.23BUSDP/E 19.4
VTRS
Viatris Inc. - Common Stock
$20.22BUSD
SOBI
Swedish Orphan Biovitrum AB
$14.24BUSDP/E 109.4
NBIX
Neurocrine Biosciences, Inc. - Common Stock
$14.55BUSDP/E 21.0
IPN
Ipsen S.A.
$12.60BUSDP/E 22.8
ELAN
Elanco Animal Health Incorporated Common Stock
$11.06BUSD
RDY
Dr. Reddy's Laboratories Ltd Common Stock
$10.20BUSDP/E 29.2
KRK
Krka, d. d.
$8.50BUSDP/E 18.4
AMRX
Amneal Pharmaceuticals, Inc. - Class A Common Stock
$7.07BUSDP/E 42.3
ALKS
Alkermes plc - Ordinary Shares
$7.00BUSDP/E 109.9
HIMS
Hims & Hers Health, Inc. Class A Common Stock
$6.77BUSD
LNTH
Lantheus Holdings, Inc. - Common Stock
$6.53BUSDP/E 23.9
KNSA
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares
$5.83BUSDP/E 76.6
INDV
Indivior Pharmaceuticals, Inc. - Common Stock
$4.21BUSDP/E 12.8

Key Statistics

Company
Market Cap1.56B USD
Enterprise Value1.87B USD
Revenue (TTM)772.89M USD
Gross Profit430.34M USD
Net Income (TTM)86.55M USD
Revenue/Share2.28 EUR
Last Price4.600 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees2.6K
CountryES
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINES0134950F36
Valuation
P/E (Trailing)17.04
P/E (Forward)12.82
PEG0.91
EV/EBITDA13.69
EV/Revenue2.42
P/S1.98
P/B1.82
EPS (TTM)0.27
EPS (Forward)0.35
52W Range
4.31525% of range5.440
52W High5.440 EUR
52W Low4.315 EUR
Profitability
Gross Margin64.85%
Oper. Margin17.04%
EBITDA Margin17.68%
Profit Margin13.04%
ROE10.69%
ROA5.93%
Growth
Revenue Growth24.00%
Earnings Growth8.90%
Cash Flow & Leverage
Operating CF85.32M USD
CapEx (TTM)25.70M USD
FCF Margin2.75%
FCF Yield1.36%
Net Debt339.68M USD
Net Debt/EBITDA2.49
Balance Sheet
Debt/Equity0.57
Current Ratio2.63
Quick Ratio1.66
Book Value/Sh2.49 EUR
Cash/Share0.44 EUR
Dividends
Fwd Div Rate0.13 EUR
Trail. Div Rate0.09 EUR
Div. Yield2.83%
5Y Avg Yield2.74%
Payout Ratio66.79%
Ex-Div DateJul 2, 2026
Pay Date—
Splits
Last Split27:26
Split DateApr 12, 2023
Analyst Consensus
Rating—
Target (Mean)5.355 EUR
Upside (mean)+16.4%
Target Range4.820 EUR – 6.000 EUR
4.820+16.4% to mean6.000
# Analysts4
Ownership
Shares Out.311.45M
Float218.33M
Insiders20.35%
Institutions15.57%
Technical
SMA 504.550 (+1.1%)
SMA 2004.748 (-3.1%)
Beta0.34
S&P 52W Chg14.58%
Avg Vol (30d)104.21K
Avg Vol (10d)250.68K
Technical Indicators
RSI (14)45.0
MACD0.0284
MACD Signal0.0346
MACD Hist.-0.0061
BB Upper4.785 EUR
BB Middle4.588 EUR
BB Lower4.392 EUR
BB Width8.55%
ATR (14)0.0824 EUR
Vol Ratio (20d)0.47x